Načítá se...
Current Clinical Trials in Non-Muscle Invasive Bladder Cancer (NIMBC)
BACKGROUND: The treatment options for non-muscle invasive bladder cancer (NMIBC) remain limited. BCG was the last major breakthrough in bladder cancer therapy almost 4 decades ago. There have been improvements in the understanding of immune therapies and cancer biology, leading to the development of...
Uloženo v:
| Vydáno v: | Urol Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5556973/ https://ncbi.nlm.nih.gov/pubmed/28778250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2017.06.043 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|